ABCB1 and neoplasm: Many Dox-resistant tumor cells have developed, having numerous possible mechanisms including alteration of the glutathione level, reduction of cytochrome P450 (CYP450)-reductase, overexpression of multidrug resistance protein 1 (MDR1), and alteration of toperisomerase II activity [7–10].